Boston Scientific logo

BSX - Boston Scientific Share Price

$38.83 1.4  3.8%

Last Trade - 05/06/20

Large Cap
Market Cap £43.81bn
Enterprise Value £51.68bn
Revenue £8.52bn
Position in Universe 175th / 6325
Unlock BSX Revenue
Relative Strength (%)
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Financial Summary
FINANCIAL BRIEF: : For the three months ended 31 March 2020, Boston Scientific Corporation revenues increased 2% to $2.54B. Net income applicable to common stockholders decreased 97% to $11M. Revenues reflect Cardiovascular segment increase of 6% to $1.03B, MedSurg segment increase of 1% to $774M, United States segment increase of 3% to $1.45B. Net income was offset by Litigation-related net charges (credits) decrease from $148M (income) to $0K.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


BSX Revenue Unlock BSX Revenue

Net Income

BSX Net Income Unlock BSX Revenue

Normalised EPS

BSX Normalised EPS Unlock BSX Revenue

PE Ratio Range

BSX PE Ratio Range Unlock BSX Revenue

Dividend Yield Range

BSX Dividend Yield Range Unlock BSX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
BSX EPS Forecasts Unlock BSX Revenue
Profile Summary

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health, Neuromodulation, and Electrophysiology. It operates in three segments: Cardiovascular, Rhythm Management and MedSurg. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Rhythm Management consists of Cardiac Rhythm Management and Electrophysiology businesses. MedSurg consists of Endoscopy, Urology and Pelvic Health, and Neuromodulation businesses. Its Interventional Cardiology product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters and embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.

Last Annual December 31st, 2019
Last Interim March 31st, 2020
Incorporated June 22, 1979
Public Since May 19, 1992
No. of Shareholders: 7,331
No. of Employees: 36,000
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index S&P Composite 1500 , S&P 500 , S&P 500 Health Care (sector),
Exchange New York Stock Exchange
Shares in Issue 1,428,693,472
Free Float (0.0%)
Eligible for
BSX Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for BSX
Upcoming Events for BSX
Wednesday 22nd July, 2020 Estimate
Q2 2020 Boston Scientific Corp Earnings Release
Wednesday 21st October, 2020 Estimate
Q3 2020 Boston Scientific Corp Earnings Release
Frequently Asked Questions for Boston Scientific
What is the Boston Scientific share price?

As of 05/06/20, shares in Boston Scientific are trading at $38.83, giving the company a market capitalisation of £43.81bn. This share price information is delayed by 15 minutes.

How has the Boston Scientific share price performed this year?

Shares in Boston Scientific are currently trading at $38.83 and the price has moved by -4.22% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Boston Scientific price has moved by -11.57% over the past year.

What are the analyst and broker recommendations for Boston Scientific?

Of the analysts with advisory recommendations for Boston Scientific, there are there are currently 11 "buy" , 2 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Boston Scientific is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Boston Scientific next release its financial results?

Boston Scientific is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-31
What is the Boston Scientific dividend yield?

Boston Scientific does not currently pay a dividend.

Does Boston Scientific pay a dividend?

Boston Scientific does not currently pay a dividend.

When does Boston Scientific next pay dividends?

Boston Scientific does not currently pay a dividend.

How do I buy Boston Scientific shares?

To buy shares in Boston Scientific you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Boston Scientific?

Shares in Boston Scientific are currently trading at $38.83, giving the company a market capitalisation of £43.81bn.

Where are Boston Scientific shares listed? Where are Boston Scientific shares listed?

Here are the trading details for Boston Scientific:

Country of listing: United States
Exchange: NYQ
Ticker Symbol: BSX
What kind of share is Boston Scientific?

Based on an overall assessment of its quality, value and momentum, Boston Scientific is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Boston Scientific share price forecast 2020?

Shares in Boston Scientific are currently priced at $38.83. At that level they are trading at 12.72% discount to the analyst consensus target price of 0.00.

Analysts covering Boston Scientific currently have a consensus Earnings Per Share (EPS) forecast of 0.966 for the next financial year.

How can I tell whether the Boston Scientific share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Boston Scientific. Over the past six months, the relative strength of its shares against the market has been -11.24%. At the current price of $38.83, shares in Boston Scientific are trading at -2.19% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Boston Scientific PE Ratio?

The Boston Scientific PE ratio based on its reported earnings over the past 12 months is 56.57. The shares are currently trading at $38.83.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Boston Scientific?

Boston Scientific's management team is headed by:

Daniel Brennan - CFO
Michael Mahoney - CHM
Joseph Fitzgerald - EVP
Kevin Ballinger - EVP
Edward Mackey - EVP
Ian Meredith - EVP
Jeffrey Mirviss - EVP
Charles Dockendorff - IND
Edward Ludwig - LED
Nelda Connors - IND
Arthur Butcher - EVP
Yoshiaki Fujimori - IND
Donna James - IND
David Pierce - EVP
Eric Thepaut - EVP
Who are the major shareholders of Boston Scientific?

Here are the top five shareholders of Boston Scientific based on the size of their shareholding:

The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 7.82% (111.7m shares)
Fidelity Management & Research Company Investment Advisor
Percentage owned: 6.8% (97.2m shares)
Capital World Investors Investment Advisor
Percentage owned: 5.65% (80.7m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 4.6% (65.7m shares)
State Street Global Advisors (US) Investment Advisor/Hedge Fund
Percentage owned: 4.36% (62.2m shares)
Similar to BSX
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.